| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.37 | $101.09 (0%) | 🛒 Add to cart |
| 60 | $2.70 | $202.18 $162.15 (20%) | 🛒 Add to cart |
| 90 | $2.49 | $303.27 $224.20 (26%) | 🛒 Add to cart |
| 120 | $2.37 | $404.36 $284.26 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $606.55 $406.37 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $909.82 $590.53 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.04 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.57 $70.06 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.09 $91.08 (7%) | 🛒 Add to cart |
| 180 | $0.73 | $147.13 $132.12 (10%) | 🛒 Add to cart |
| 270 | $0.72 | $220.70 $195.18 (12%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $294.27 $257.23 (13%) | 🛒 Add to cart |
Similar products
More info:
diltiazem
Diltiazem hydrochloride is a calcium channel blocker medication primarily used in cardiovascular medicine, though we’ve discovered some fascinating off-label applications over the years. It’s interesting how this compound, initially developed for hypertension and angina, has revealed unexpected therapeutic dimensions that continue to surprise even seasoned clinicians. I remember when we first started working with diltiazem in the late 1980s - the initial focus was purely on its cardiovascular effects, but we quickly noticed some peculiar patterns in patients with certain esophageal conditions.
Adalat: Potent Vasodilation for Hypertension and Angina - Evidence-Based Review
Nifedipine, marketed under the brand name Adalat, represents a cornerstone in cardiovascular pharmacotherapy as a first-generation dihydropyridine calcium channel blocker. Initially developed by Bayer in the 1970s, this medication fundamentally changed hypertension and angina management by offering a novel mechanism of action compared to existing beta-blockers and diuretics. The introduction of Adalat provided clinicians with a potent vasodilator that specifically targeted peripheral arterial resistance without significant effects on cardiac contractility at therapeutic doses.
betapace
Betapace, known generically as sotalol hydrochloride, represents one of those fascinating compounds that straddles the line between simple beta-blocker and sophisticated antiarrhythmic. It’s not your typical metoprolol or atenolol - the molecule has this unique dual mechanism that still surprises some cardiologists who haven’t worked with it extensively. When I first encountered Betapace during my fellowship at Massachusetts General, I’ll admit I underestimated its complexity. We had this 68-year-old retired schoolteacher, Eleanor, with persistent atrial fibrillation despite being on digoxin and verapamil.
buspar
Buspirone hydrochloride represents one of the more interesting anxiolytics in our modern pharmacopeia - it’s neither a benzodiazepine nor an SSRI, but occupies this unique pharmacological niche that I’ve found particularly valuable in specific patient populations. The drug came to market in the 1980s, but honestly, we’re still uncovering new aspects of its mechanism and potential applications even now. What makes buspirone clinically distinctive is its azapirone chemical structure and its primary action as a partial agonist at serotonin 5-HT1A receptors.
Calan: Effective Cardiovascular Management for Hypertension and Arrhythmias - Evidence-Based Review
Calan, known generically as verapamil, is a calcium channel blocker medication primarily used for managing cardiovascular conditions like hypertension, angina, and certain arrhythmias. It works by inhibiting calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced heart workload. Available in immediate and sustained-release formulations, Calan requires careful dosing and monitoring due to potential interactions and contraindications. Its evidence base is robust, supported by decades of clinical use and research, making it a cornerstone in cardiology practice.
Cardizem: Effective Blood Pressure and Heart Rhythm Control - Evidence-Based Review
Cardizem, known generically as diltiazem, is a calcium channel blocker primarily prescribed for managing cardiovascular conditions like hypertension, chronic stable angina, and certain arrhythmias. It functions by inhibiting calcium ion influx across cardiac and vascular smooth muscle cell membranes, leading to coronary and peripheral vasodilation, reduced myocardial oxygen demand, and slowed atrioventricular nodal conduction. Available in immediate-release, extended-release, and intravenous formulations, Cardizem’s pharmacokinetics allow tailored dosing regimens to suit individual patient profiles and therapeutic goals.
coreg
Coreg, known generically as carvedilol, is a non-selective beta-blocker with additional alpha-1 blocking activity, primarily used in cardiovascular medicine for managing heart failure, hypertension, and post-myocardial infarction left ventricular dysfunction. It’s not a dietary supplement but a prescription medication that requires careful titration and monitoring due to its significant hemodynamic effects. 1. Introduction: What is Coreg? Its Role in Modern Medicine Coreg (carvedilol) represents a critical advancement in the pharmacological management of chronic heart failure and related cardiovascular conditions.
Erythromycin: Effective Bacterial Infection Treatment - Evidence-Based Review
Erythromycin represents one of the foundational macrolide antibiotics that fundamentally reshaped infectious disease management when introduced in the 1950s. Derived from Saccharopolyspora erythraea, this bacteriostatic antimicrobial continues to play crucial roles in both community and hospital settings despite the emergence of newer agents. Its unique spectrum and safety profile maintain its relevance across multiple specialties. 1. Introduction: What is Erythromycin? Its Role in Modern Medicine Erythromycin belongs to the macrolide class of antibiotics, characterized by a macrocyclic lactone ring structure that enables unique binding to bacterial ribosomes.
Inderal: Comprehensive Beta-Blocker Therapy for Cardiovascular and Neurological Conditions - Evidence-Based Review
Product Description: Inderal, known generically as propranolol hydrochloride, represents one of the foundational beta-blockers in cardiovascular and neurological therapeutics. As a non-selective beta-adrenergic antagonist, it competitively blocks catecholamine effects at both β1 and β2 receptors, producing a wide spectrum of physiological responses from reduced heart rate and blood pressure to decreased tremor amplitude and anxiety symptoms. Available in immediate-release (10mg, 20mg, 40mg, 80mg tablets) and long-acting formulations (60mg, 80mg, 120mg, 160mg capsules), its therapeutic applications extend far beyond its original cardiovascular indications.